In his second appearance on the show, Christopher Booth, MD, Professor in the Departments of Oncology and Medicine as well as a Health Services Researcher, Queen’s University (Canada), shares his unique career path and early considerations of conflicts of interest in the medical world, how the influences of pharma relationships are more subtle than expected, whether you can be a clinical trialist without working with pharma, and how the system can be changed to truly benefit patients. Additionally, Chadi and Dr. Booth hit on painpoints including patient enrollment, pharma-sponsored conference sessions, satellite symposiums, patient advocacy groups and advocacy societies, global relevancy of “suboptimal” control arms in clinical trials, and more.
Observations and Commentary on Medicine and Current Events
